Miranda-Gonçalves, V., Gonçalves, C. S., Granja, S. C., Castro, J. I. M. C. V., Reis, R. M., Costa, B. M., & Baltazar, F. (2021). MCT1 is a new prognostic biomarker and its therapeutic inhibition boosts response to temozolomide in human glioblastoma.
Citação norma ChicagoMiranda-Gonçalves, Vera, Celine Saraiva Gonçalves, Sara Costa Granja, Joana Isabel Martins Cosme Vieira Castro, Rui M. Reis, Bruno M. Costa, and Fátima Baltazar. MCT1 Is a New Prognostic Biomarker and Its Therapeutic Inhibition Boosts Response to Temozolomide in Human Glioblastoma. 2021.
Citação norma MLAMiranda-Gonçalves, Vera, et al. MCT1 Is a New Prognostic Biomarker and Its Therapeutic Inhibition Boosts Response to Temozolomide in Human Glioblastoma. 2021.